Company profile: Seagen
1.1 - Company Overview
Company description
- Provider of monoclonal antibody-based therapies and advanced antibody-drug conjugate technology focused on improving patient outcomes in cancer and autoimmune diseases. Lead program SGN-35 is in a pivotal trial for patients with relapsed or refractory Hodgkin lymphoma.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Seagen
Normunity
HQ: United States
Website
- Description: Provider of precision immuno-oncology medicines focused on immune normalizers—novel cancer immunotherapies that restore normal immune responses. Includes the Chen Lab Discovery Platform to identify and validate novel targets and Normunity Drug Development to create monoclonal antibodies based on these discoveries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Normunity company profile →
Cardiff Oncology
HQ: United States
Website
- Description: Provider of oncology therapeutics targeting cell division, including onvansertib, a PLK1 inhibitor evaluated with standard-of-care treatments for cancers such as metastatic colorectal cancer and pancreatic ductal adenocarcinoma; includes Clinical Trial CRDF-004 assessing onvansertib with standard care in KRAS- or NRAS-mutated metastatic colorectal cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardiff Oncology company profile →
Siren Biotechnology
HQ: United States
Website
- Description: Provider of AAV immuno-gene therapies that combine AAV gene therapy and cytokine immunotherapy into a single modality for solid tumors, including brain and eye cancers. Its approach delivers engineered cytokines directly to tumors to activate immune responses and destroy cancer cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Siren Biotechnology company profile →
Galil Medical
HQ: United States
Website
- Description: Provider of minimally invasive cryotherapy technology and systems for various clinical applications, using compressed Argon gas to freeze and ablate diseased tissue in procedures referred to as cryotherapy, cryoablation, or cryosurgery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Galil Medical company profile →
Oncovision
HQ: Mexico
Website
- Description: Provider of molecular vision solutions for the health sciences sector, supporting cancer diagnosis and treatment and advanced research in neurology, oncology, and cardiology. Spanish technology start-up founded in 2003 by the Corpuscular Physics Institute (CSIC) and the University of Valencia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oncovision company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Seagen
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Seagen
2.2 - Growth funds investing in similar companies to Seagen
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Seagen
4.2 - Public trading comparable groups for Seagen
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →